BAXS Stock UPDATES Baxano Surgical Inc (BAXS) 0.23 10/28/2014

New Post Public Reply Private Reply Replies (0) Message Board

Oct 28, 2014 at 5:28 PM

Baxano Surgical Inc (BAXS) 0.23 $BAXS

Most active Nasdaq-traded stocks
AP - Tue Oct 28, 12:25PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
BAXS: 0.23 (+0.07), MU: 32.61 (+0.31), FB: 80.77 (+0.49), MSFT: 46.49 (+0.58), INTC: 33.74 (+0.54), AAPL: 106.74 (+1.63)

5 Stocks Under $10 Set to Soar
at The Street - Fri Oct 24, 1:39PM CDT
These under-$10 stocks look ready to trade higher from current levels.
BAXS: 0.23 (+0.07), FOMX: 5.46 (+0.13), ARCO: 6.22 (+0.16), SNSS: 1.74 (+0.01), SZMK: 5.75 (+0.20)

Baxano Surgical Completes Financing and Continues Streamlined Business Operations
GlobeNewswire - Thu Sep 25, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, announced that the Company has completed a recent subordinated convertible note financing of approximately $1.5 million to extend its cash runway. In connection with the financing, the Company has also streamlined its business to reduce its operating expenses while maintaining its commercial operations.
BAXS: 0.23 (+0.07)

Baxano Surgical to Explore Strategic Alternatives for Its MIS Spine Business
GlobeNewswire - Thu Sep 18, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company has engaged Houlihan Lokey as its financial advisor to advise it on potential strategic alternatives for the Company's business.
BAXS: 0.23 (+0.07)

Baxano Surgical to Train 35 Surgeons on Advanced MIS Techniques
GlobeNewswire - Fri Sep 12, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Company is participating in an MIS-based training course hosted by the International Society for the Advancement of Spine Surgery (ISASS), and co-chaired by Anthony Yeung, MD and James J Yue, MD.
BAXS: 0.23 (+0.07)

Baxano Surgical, Inc. Reports Operating Results for the Second Quarter of 2014, Issues Third Quarter 2014 Guidance
GlobeNewswire - Tue Aug 05, 3:08PM CDT
- Second quarter revenue of $4.7 million, representing year-over-year growth of 20.1% and sequential growth of 5.5% -
BAXS: 0.23 (+0.07)

Baxano Surgical, Inc. Announces Two New Patents for VEO Direct Lateral and AxiaLIF Minimally Invasive Interbody Fusion Systems
GlobeNewswire - Tue Aug 05, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the United States Patent and Trademark Office has issued two patents on key Baxano Surgical technologies, bringing the company's patent portfolio to 92 patents in the U.S.
BAXS: 0.23 (+0.07)

Baxano Surgical Announces Second Quarter 2014 Earnings Conference Call and Webcast
GlobeNewswire - Thu Jul 24, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that it will release second quarter 2014 financial results on Tuesday, August 5, 2014 after the market closes. Ken Reali, President and Chief Executive Officer and Tim Shannon, Chief Financial Officer, will then conduct a conference call at 4:30 pm ET to review the results.
BAXS: 0.23 (+0.07)

Economic Analysis of Minimally Invasive Spine Fusion Using AxiaLIF Accepted for Publication in the Journal of Managed Care Medicine
GlobeNewswire - Fri Jul 18, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the Journal of Managed Care Medicine, a peer-reviewed national publication, has accepted an economic analysis of the AxiaLIF pre-sacral interbody fusion procedure in comparison to transforaminal lumbar interbody fusion (TLIF).
BAXS: 0.23 (+0.07)

Baxano Surgical Announces First Clinical Use of the Avance MIS Pedicle Screw System
GlobeNewswire - Mon Jun 30, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the lumbar spine, today announced that the first case utilizing the Avance(TM) MIS Pedicle Screw System was recently performed by Dr. Sameer Mathur in Cary, NC. The innovative design of Avance provides for an easy-to-use, percutaneous pedicle screw system that addresses single, complex and multi-level spinal pathologies with minimal tissue disruption and trauma. The Avance system will be in limited market release through the end of third quarter of 2014 and is planned for full launch in the fourth quarter of 2014.
BAXS: 0.23 (+0.07)

Baxano Surgical to Present at JMP Securities Healthcare Conference
GlobeNewswire - Mon Jun 16, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that the Company's CEO, Ken Reali, will present at the JMP Securities Healthcare Conference in New York on June 24, 2014. The Company's presentation is scheduled to begin at 2:00 pm EDT and will be taking place in the Grand Central Ballroom D at The Westin New York Grand Central.
BAXS: 0.23 (+0.07)

Baxano Surgical, Inc. Announces Changes to Executive Management Team
GlobeNewswire - Fri Mar 14, 11:00AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS), a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, today announced changes to its executive management team.
BAXS: 0.23 (+0.07)

Baxano Surgical, Inc. Announces $10 Million Private Placement of Convertible Debentures
GlobeNewswire - Tue Mar 11, 6:30AM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS) ("Baxano Surgical" or the "Company"

, a medical device company focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region, announced today that it has entered into a definitive agreement with entities affiliated with two institutional investors in connection with a private placement of approximately $10 million aggregate principal amount of subordinated convertible debentures and warrants to purchase 9,428,000 shares of common stock. Prior to the closing of the private placement, the Company is required to obtain stockholder approval to increase the total number of its authorized shares of common stock and to approve the issuance of common stock pursuant to the debentures and warrants.
BAXS: 0.23 (+0.07)

Baxano Surgical Announces Participation in Canaccord Genuity Musculoskeletal Conference
GlobeNewswire - Fri Mar 07, 6:30AM CST
Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it will participate in the Canaccord Genuity Musculoskeletal Conference on March 11, 2014.
BAXS: 0.23 (+0.07)

Baxano Surgical, Inc. Reports Operating Results for the Fourth Quarter of 2013, Issues First Quarter 2014 Guidance
GlobeNewswire - Fri Mar 07, 2:59AM CST
- Fourth Quarter Revenue Was $6.0 Million -
BAXS: 0.23 (+0.07)

Baxano Surgical Schedules Fourth Quarter 2013 Results Conference Call for Thursday, March 6, 2014
GlobeNewswire - Mon Mar 03, 6:30AM CST
Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans to release fourth quarter 2013 financial and operating results after market close on Thursday, March 6, 2014. Ken Reali, President and Chief Executive Officer of Baxano Surgical, and Tim Shannon, Interim Chief Financial Officer, will host a conference call starting at 4:30 pm ET on the same day. To listen to the conference call on your telephone, please dial (877) 312-8823 for domestic callers and (253) 237-1182 for international callers approximately ten minutes prior to the start time. The call will be concurrently webcast. To access the live audio broadcast or archived recording, use the following link at http://ir.baxanosurgical.com/events.cfm.
BAXS: 0.23 (+0.07)

Baxano Surgical, Inc. Announces Changes to Management Team
GlobeNewswire - Fri Sep 20, 11:00AM CDT
Third Quarter and Full Year Revenue Guidance Reaffirmed
BAXS: 0.23 (+0.07)

Baxano Surgical, Inc. Schedules Second Quarter 2013 Results Conference Call for Thursday, August 8, 2013
GlobeNewswire - Thu Jul 25, 3:44PM CDT
Baxano Surgical, Inc. (Nasdaq:BAXS) announced today that it plans to release second quarter 2013 financial and operating results after market close on Thursday, August 8, 2013. Ken Reali, President and Chief Executive Officer and Joe Slattery, Chief Financial Officer, will host a conference call starting at 4:30 pm ET on the same day. To listen to the conference call on your telephone, please dial (877) 312-8823 for domestic callers and (253) 237-1182 for international callers approximately ten minutes prior to the start time. The call will be concurrently webcast. To access the live audio broadcast or archived recording, use the following link at http://ir.baxanosurgical.com/eventdetail.cfm?eventid=132615.
BAXS: 0.23 (+0.07)

Abbott Beats on Earnings in 2Q, Reiterates Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 17, 8:40AM CDT
Abbott reported second quarter 2013 earnings of 46 cents per share, beating the Zacks Consensus Estimate of 44 cents.
BAXS: 0.23 (+0.07), ABT: 42.50 (+0.26), LMAT: 7.09 (+0.05), ABBV: 60.93 (+0.44)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KAPSARC Drives Energy Dialogue at WPC in Riyadh

Defining Energy Horizons in Riyadh Mark those calendars, because as the global energy crowd descends on Riyadh from October 11 to 15, 2026, KAPSARC steps into the spotlight. As the National Partner at the 25th World Petroleum Congress (WPC), they're not just warming the bench—they're playing every position, shaking up the field of energy. Paving the Pathways with...

Emdoor’s Rugged Devices Fuel Industry Growth Globally

Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...

RingConn Smart Ring Gains Key FDA 510(k) Clearance

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...

Kexing Biopharm Expands Global Reach at CPHI Milan

Kexing Biopharm's Showstopper Moment in Milan Call it a strategic blowout or just audacious timing—Kexing Biopharm's move at the CPHI Milan 2026 has painted a clear picture. From October 6th to 8th, Milan was the stage where Kexing rolled out its showcase, bragging about a pipeline that screams innovation and possibility. And let’s be honest, their timing couldn’t...

New Docs Spotlight Psychiatry on World Mental Health Day

Unmasking Mental Health on the Global Stage Hold onto your hats, folks. The Scientology Network is cranking up the heat this World Mental Health Day. On October 10, they’re rolling out a program that puts the spotlight on CCHR’s crusade against what they see as dark forces in the psychiatric industry. It’s a marathon of documentaries that dives into allegations of...

ONLYOFFICE 10.0 Boosts AI and Security Features

A Fresh Look at ONLYOFFICE 10.0's Game-Changing Update Outta the gates swinging, ONLYOFFICE dropped their latest 10.0 update. This one ain't just your average software facelift—it's packing some serious heat with AI enhancements, brand spanking new modular apps, and beefed-up security features that'll make anyone dealing with sensitive data breathe a little easier. AI...

Tchah Sup Kim: A Retrospective at KCCNY in 2026

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Jiangxi Dialogues: Youths Forge Global Ties in 2026

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

AI in Music: CITY JAM Focuses on Human Creativity

Breaking Down the AI Music Race In the wild world of music production, AI's making waves. Here's the thing though—it's all about how fast and how much it can churn out. Now, won't lie to you, that's impressive, but not the full picture. Pat Villaceran, the brain behind CITY JAM, is adamant that the real gold isn't just speed. It's the unique sound each artist brings to...

tm:rw Revolutionizes Retail with Live TikTok Studios

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...